EcoR1 Capital, LLC
Insider CIK 1587114 · ANAB Director, 10% owner · MRSN 10% owner · PRTA 10% owner · ATRA 10% owner · ADAP 10% owner · CRVS 10% owner · VYGR 10% owner · ODT 10% owner · SURF 10% owner · AKUS 10% owner · ITOS 10% owner · PANA Director, 10% owner · TNGX 10% owner · PANA Director, 10% owner · ZYME Director, 10% owner · AKTS Director · TRAX 10% owner · GNVC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics, Inc | P Buy | 2026-05-07 | 2026-05-11 | 507,407 | $9.35 | $4.74M | 1,552,000 | SEC↗ |
| TRAX First Tracks Biotherapeuti | S Sale | 2026-04-20 | 2026-04-22 | 4,705,575 | $13.81 | $64.98M | 3,174,519 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 102,500 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 86,222 | — | $0 | 86,222 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 965,190 | — | $0 | 965,190 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 2,397,500 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 488,891 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 997,299 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 9,913,810 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 144,443 | $18.00 | $2.60M | 347,305 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 2,270,879 | — | $0 | 2,270,879 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 202,862 | — | $0 | 202,862 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 128,506 | — | $0 | 128,506 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 2,077,779 | $18.00 | $37.40M | 4,348,658 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-07-30 | 2025-07-30 | 27,433,338 | $0.10 | $2.74M | 100,371,882 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-07-29 | 2025-07-30 | 2,687,460 | $0.10 | $268.7K | 127,805,220 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-07-28 | 2025-07-30 | 33,931,740 | $0.11 | $3.73M | 130,492,680 | SEC↗ |
| ZYME Zymeworks Inc. | X Exercise deriv | 2025-06-26 | 2025-06-27 | 5,086,521 | — | $0 | 0 | SEC↗ |
| ZYME Zymeworks Inc. | F Tax w/h | 2025-06-26 | 2025-06-27 | 41 | $12.71 | $521 | 22,970,388 | SEC↗ |
| ZYME Zymeworks Inc. | X Exercise | 2025-06-26 | 2025-06-27 | 5,086,480 | — | $0 | 22,970,388 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-05-19 | 2025-05-19 | 5,919 | $11.78 | $69.7K | 17,883,908 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2025-05-15 | 2025-05-16 | 3,300,000 | $8.00 | $26.40M | 10,688,978 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-05-15 | 2025-05-19 | 49,502 | $11.43 | $565.8K | 17,877,989 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2025-05-14 | 2025-05-16 | 1,658,978 | $7.41 | $12.29M | 7,388,978 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2025-05-06 | 2025-05-06 | 1,984,053 | $7.64 | $15.16M | 5,304,596 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2025-05-05 | 2025-05-06 | 977,693 | $8.11 | $7.93M | 7,288,649 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2025-05-02 | 2025-05-06 | 3,317,938 | $8.36 | $27.74M | 8,266,342 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-17 | 2025-04-18 | 54,760 | $11.52 | $630.8K | 17,828,487 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-16 | 2025-04-18 | 73,953 | $11.16 | $825.3K | 17,773,727 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-04 | 2025-04-07 | 196,438 | $11.17 | $2.19M | 17,699,774 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-03 | 2025-04-07 | 120,770 | $11.84 | $1.43M | 17,503,336 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-02 | 2025-04-02 | 74,360 | $11.85 | $881.2K | 17,382,566 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-01 | 2025-04-02 | 48,658 | $11.60 | $564.4K | 17,308,206 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-31 | 2025-04-02 | 4,397 | $11.75 | $51.7K | 17,259,548 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-26 | 2025-03-27 | 43,848 | $12.24 | $536.7K | 17,255,151 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-25 | 2025-03-27 | 53,501 | $12.91 | $690.7K | 17,211,303 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-24 | 2025-03-24 | 22,689 | $13.08 | $296.8K | 17,157,802 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-21 | 2025-03-24 | 31,033 | $12.78 | $396.6K | 17,135,113 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-20 | 2025-03-24 | 73,476 | $12.93 | $950.0K | 17,104,080 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-19 | 2025-03-19 | 58,306 | $12.64 | $737.0K | 17,030,604 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-18 | 2025-03-19 | 113,880 | $12.65 | $1.44M | 16,972,298 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-17 | 2025-03-19 | 56,277 | $12.23 | $688.3K | 16,858,418 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-13 | 2025-03-13 | 468,356 | $12.48 | $5.85M | 16,802,141 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-12 | 2025-03-13 | 292,934 | $12.25 | $3.59M | 16,333,785 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-11 | 2025-03-13 | 320,690 | $11.49 | $3.68M | 16,040,851 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-17 | 2025-01-21 | 19,748 | $13.87 | $273.9K | 15,720,161 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-16 | 2025-01-21 | 121,681 | $13.89 | $1.69M | 15,700,413 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-15 | 2025-01-15 | 39,029 | $14.01 | $546.8K | 15,578,732 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-14 | 2025-01-15 | 54,500 | $13.56 | $739.0K | 15,539,703 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-13 | 2025-01-15 | 74,125 | $13.39 | $992.5K | 15,485,203 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-10 | 2025-01-10 | 204,098 | $13.13 | $2.68M | 15,411,078 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-08 | 2025-01-10 | 21,021 | $14.07 | $295.8K | 15,206,980 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-01-02 | 2025-01-02 | 157,880 | $14.78 | $2.33M | 15,185,959 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2025-01-02 | 2025-01-02 | 6,646 | $12.95 | $86.1K | 7,880,094 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-31 | 2025-01-02 | 146,501 | $14.57 | $2.13M | 15,028,079 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2024-12-31 | 2025-01-02 | 13,268 | $12.93 | $171.6K | 7,873,448 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-30 | 2025-01-02 | 58,988 | $14.47 | $853.6K | 14,881,578 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2024-12-30 | 2025-01-02 | 65,184 | $12.92 | $842.2K | 7,860,180 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-27 | 2024-12-27 | 101,659 | $14.49 | $1.47M | 14,822,590 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-26 | 2024-12-27 | 16,692 | $14.38 | $240.0K | 14,720,931 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-24 | 2024-12-27 | 11,958 | $14.12 | $168.8K | 14,704,239 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-23 | 2024-12-26 | 251,502 | $14.25 | $3.58M | 14,692,281 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-20 | 2024-12-26 | 704,488 | $14.08 | $9.92M | 14,440,779 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other deriv | 2024-12-19 | 2024-12-23 | 8,036,688 | — | $0 | 8,036,688 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2024-12-19 | 2024-12-23 | 8,036,688 | — | $0 | 11,328,000 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2024-12-19 | 2024-12-26 | 298,818 | $13.53 | $4.04M | 13,736,291 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 1,143,124 | $2.92 | $3.34M | 10,630,736 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 62,318 | $3.29 | $205.0K | 11,773,860 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 1,494,558 | $3.28 | $4.90M | 11,836,178 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2024-08-14 | 2024-08-16 | 273,972 | $36.50 | $10.00M | 7,794,996 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy deriv | 2023-12-26 | 2024-12-23 | 5,086,521 | $9.83 | $50.00M | 5,086,521 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy deriv | 2023-12-26 | 2023-12-28 | 5,086,521 | $9.83 | $50.00M | 5,086,521 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-09-21 | 2023-09-22 | 53,000 | $1.36 | $72.1K | 12,674,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-09-20 | 2023-09-22 | 117,100 | $1.36 | $159.3K | 12,621,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-09-19 | 2023-09-22 | 5,143,000 | $1.26 | $6.48M | 12,504,675 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-06-16 | 2023-06-21 | 3,350,000 | $8.12 | $27.20M | 13,437,473 | SEC↗ |
| PANA Panacea Acquisition Corp. | D To issuer | 2023-04-28 | 2023-05-02 | 545,000 | — | $0 | 0 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-03-28 | 2023-03-30 | 200,000 | $8.00 | $1.60M | 10,087,473 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-02-21 | 2023-09-21 | 53,000 | $1.36 | $72.1K | 12,674,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-02-20 | 2023-09-21 | 117,100 | $1.36 | $159.3K | 12,621,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-02-19 | 2023-09-21 | 5,143,000 | $1.26 | $6.48M | 12,504,675 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-01-20 | 2023-01-23 | 163,400 | $9.88 | $1.61M | 9,887,473 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-01-19 | 2023-01-23 | 144,100 | $9.49 | $1.37M | 9,724,073 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-01-18 | 2023-01-18 | 203,000 | $10.00 | $2.03M | 9,579,973 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-01-17 | 2023-01-18 | 440,000 | $9.80 | $4.31M | 9,376,973 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-01-13 | 2023-01-18 | 342,100 | $9.81 | $3.36M | 8,936,973 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-11 | 2023-01-11 | 110,000 | $8.50 | $935.0K | 3,851,507 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-01-11 | 2023-01-12 | 106,300 | $7.87 | $836.6K | 8,594,873 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-10 | 2023-01-11 | 336,400 | $8.05 | $2.71M | 3,961,507 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2023-01-10 | 2023-01-12 | 920,000 | $7.65 | $7.04M | 8,488,573 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-11 | 456,000 | $7.67 | $3.50M | 4,297,907 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | P Buy | 2022-06-23 | 2022-06-23 | 376,000 | $5.66 | $2.13M | 4,753,907 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | P Buy | 2022-06-21 | 2022-06-23 | 101,400 | $5.28 | $535.4K | 4,377,907 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-05-05 | 2022-05-09 | 1,062,736 | $29.02 | $30.84M | 11,584,280 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2022-05-05 | 2022-05-09 | 1,062,736 | $29.02 | $30.84M | 11,584,280 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2022-05-05 | 2022-05-09 | 668,237 | $21.63 | $14.45M | 7,521,024 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2022-05-05 | 2022-05-09 | 668,237 | $21.63 | $14.45M | 7,521,024 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2022-01-12 | 2022-01-12 | 300,000 | $37.50 | $11.25M | 11,584,280 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-12-10 | 2021-12-10 | 545,000 | $1.55 | $844.8K | 0 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-12-10 | 2021-12-10 | 5,000,000 | $1.66 | $8.30M | 545,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-12-09 | 2021-12-10 | 156,669 | $1.82 | $285.1K | 5,545,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2021-12-01 | 2021-12-10 | 185,941 | $1.66 | $308.7K | 5,701,669 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-10 | 185,941 | $1.66 | $308.7K | 5,701,669 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-11-24 | 2021-11-30 | 21,758 | $7.69 | $167.3K | 1,169,241 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-11-24 | 2021-11-30 | 163,268 | $7.69 | $1.26M | 7,361,675 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | S Sale | 2021-10-01 | 2021-10-01 | 2,000,000 | $4.96 | $9.92M | 81,077 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | S Sale | 2021-09-30 | 2021-10-01 | 3,000,000 | $5.04 | $15.12M | 2,081,077 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-07-31 | 2021-11-30 | 56,598 | $8.64 | $489.0K | 7,198,407 | SEC↗ |
| NUVB Nuvation Bio Inc. | S Sale | 2021-07-31 | 2021-11-30 | 56,598 | $8.64 | $489.0K | 1,147,483 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | X Exercise deriv | 2021-06-18 | 2021-06-22 | 2,500 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | X Exercise | 2021-06-18 | 2021-06-22 | 250,000 | $30.00 | $7.50M | 11,284,280 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-05-04 | 2021-05-04 | 165,000 | $23.25 | $3.84M | 7,520,424 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-05-03 | 2021-05-04 | 20,800 | $23.31 | $484.8K | 7,355,424 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-30 | 2021-05-04 | 35,700 | $23.16 | $826.8K | 7,334,624 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-27 | 2021-04-27 | 33,800 | $23.82 | $805.1K | 7,298,924 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-26 | 2021-04-27 | 13,900 | $23.80 | $330.8K | 7,265,124 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-23 | 2021-04-27 | 99,600 | $23.54 | $2.34M | 7,251,224 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-13 | 2021-04-13 | 27,534 | $10.27 | $282.8K | 6,990,265 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-13 | 2021-04-13 | 3,966 | $10.27 | $40.7K | 1,355,625 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-12 | 2021-04-13 | 116,255 | $9.49 | $1.10M | 6,962,731 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-12 | 2021-04-13 | 16,745 | $9.49 | $158.9K | 1,351,659 | SEC↗ |
| PANA Panacea Acquisition Corp. | P Buy | 2021-04-09 | 2021-04-13 | 545,000 | $10.00 | $5.45M | 545,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-09 | 2021-04-13 | 37,770 | $10.03 | $378.8K | 1,334,914 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-09 | 2021-04-13 | 262,230 | $10.03 | $2.63M | 6,846,476 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-03-31 | 2021-11-30 | 151,544 | $10.45 | $1.58M | 6,735,790 | SEC↗ |
| NUVB Nuvation Bio Inc. | S Sale | 2021-03-31 | 2021-11-30 | 151,544 | $10.45 | $1.58M | 1,145,600 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-03-24 | 2021-03-25 | 875,000 | $20.75 | $18.16M | 11,034,280 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-03-09 | 2021-03-10 | 531,000 | $18.70 | $9.93M | 7,151,624 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-03-08 | 2021-03-10 | 2,777,800 | $18.97 | $52.69M | 6,620,624 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-24 | 2021-02-25 | 10,800 | $22.02 | $237.8K | 10,159,280 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-02-23 | 2021-02-25 | 29,500 | $25.48 | $751.7K | 3,842,824 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-23 | 2021-02-25 | 44,400 | $21.05 | $934.6K | 10,148,480 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-18 | 2021-02-22 | 44,100 | $3.68 | $162.3K | 10,104,080 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-18 | 2021-02-23 | 44,100 | $23.65 | $1.04M | 10,104,080 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy deriv | 2021-02-17 | 2021-02-17 | 2,500 | $3.68 | $9.2K | 2,500 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy deriv | 2021-02-17 | 2021-02-26 | 2,500 | $3.68 | $9.2K | 2,500 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-17 | 2021-02-17 | 198,840 | $23.46 | $4.66M | 10,059,980 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-16 | 2021-02-17 | 89,200 | $22.78 | $2.03M | 9,861,140 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-12 | 2021-02-17 | 282,800 | $20.08 | $5.68M | 9,771,940 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | P Buy | 2021-02-12 | 2021-02-17 | 62,500 | $20.50 | $1.28M | 9,489,140 | SEC↗ |
| NUVB Nuvation Bio Inc. | C Conversion deriv | 2021-02-10 | 2021-02-12 | 2,775,000 | — | $0 | 0 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 702,000 | — | $0 | 702,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 131,333 | — | $0 | 131,333 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 130,000 | — | $0 | 130,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,365,511 | — | $0 | 6,584,246 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 387,265 | $10.00 | $3.87M | 781,265 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,112,735 | $10.00 | $21.13M | 4,218,735 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,200,627 | — | $0 | 2,200,627 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,106,000 | — | $0 | 2,106,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | C Conversion | 2021-02-10 | 2021-02-12 | 2,775,000 | — | $0 | 3,165,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 515,879 | — | $0 | 1,297,144 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 394,000 | — | $0 | 394,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2020-09-01 | 2020-09-03 | 332,780 | $7.14 | $2.38M | 4,701,081 | SEC↗ |
| PANA Panacea Acquisition Corp | P Buy | 2020-07-06 | 2020-07-06 | 390,000 | $10.00 | $3.90M | 390,000 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 16,858,076 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-02 | 1,176,000 | $17.00 | $19.99M | 1,975,984 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 799,984 | — | $0 | 799,984 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-27 | 2014-05-27 | 4,662 | $2.39 | $11.1K | 1,024,358 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-27 | 2014-05-27 | 4,378 | $2.39 | $10.5K | 962,055 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-23 | 2014-05-27 | 2,372 | $2.19 | $5.2K | 1,019,696 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-23 | 2014-05-27 | 2,228 | $2.19 | $4.9K | 957,677 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-22 | 2014-05-27 | 5,085 | $2.13 | $10.8K | 955,449 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-22 | 2014-05-27 | 5,415 | $2.13 | $11.5K | 1,017,324 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-28 | 2014-03-28 | 19,006 | $2.73 | $51.9K | 785,366 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-28 | 2014-03-28 | 28,509 | $2.73 | $77.8K | 1,176,907 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-27 | 2014-03-28 | 30,729 | $2.49 | $76.5K | 1,148,398 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-27 | 2014-03-28 | 20,486 | $2.49 | $51.0K | 766,360 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-26 | 2014-03-28 | 9,417 | $2.31 | $21.8K | 745,874 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-26 | 2014-03-28 | 14,126 | $2.31 | $32.6K | 1,117,669 | SEC↗ |